Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Cerebrospinal fluid tau fragment correlates with tau PET: a candidate biomarker for tangle pathology.

Blennow K, Chen C, Cicognola C, Wildsmith KR, Manser PT, Bohorquez SMS, Zhang Z, Xie B, Peng J, Hansson O, Kvartsberg H, Portelius E, Zetterberg H, Lashley T, Brinkmalm G, Kerchner GA, Weimer RM, Ye K, Höglund K.

Brain. 2019 Dec 13. pii: awz346. doi: 10.1093/brain/awz346. [Epub ahead of print]

PMID:
31834365
2.

Gantenerumab reduces amyloid-β plaques in patients with prodromal to moderate Alzheimer's disease: a PET substudy interim analysis.

Klein G, Delmar P, Voyle N, Rehal S, Hofmann C, Abi-Saab D, Andjelkovic M, Ristic S, Wang G, Bateman R, Kerchner GA, Baudler M, Fontoura P, Doody R.

Alzheimers Res Ther. 2019 Dec 12;11(1):101. doi: 10.1186/s13195-019-0559-z.

PMID:
31831056
3.

Cross-sectional associations between [18F]GTP1 tau PET and cognition in Alzheimer's disease.

Teng E, Ward M, Manser PT, Sanabria-Bohorquez S, Ray RD, Wildsmith KR, Baker S, Kerchner GA, Weimer RM.

Neurobiol Aging. 2019 Sep;81:138-145. doi: 10.1016/j.neurobiolaging.2019.05.026. Epub 2019 Jun 6.

PMID:
31280117
4.

[18F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's disease.

Sanabria Bohórquez S, Marik J, Ogasawara A, Tinianow JN, Gill HS, Barret O, Tamagnan G, Alagille D, Ayalon G, Manser P, Bengtsson T, Ward M, Williams SP, Kerchner GA, Seibyl JP, Marek K, Weimer RM.

Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2077-2089. doi: 10.1007/s00259-019-04399-0. Epub 2019 Jun 28.

PMID:
31254035
5.

Hippocampal CA1 subfield predicts episodic memory impairment in Parkinson's disease.

La C, Linortner P, Bernstein JD, Ua Cruadhlaoich MAI, Fenesy M, Deutsch GK, Rutt BK, Tian L, Wagner AD, Zeineh M, Kerchner GA, Poston KL.

Neuroimage Clin. 2019;23:101824. doi: 10.1016/j.nicl.2019.101824. Epub 2019 Apr 18.

6.

Safety, Tolerability, and Feasibility of Young Plasma Infusion in the Plasma for Alzheimer Symptom Amelioration Study: A Randomized Clinical Trial.

Sha SJ, Deutsch GK, Tian L, Richardson K, Coburn M, Gaudioso JL, Marcal T, Solomon E, Boumis A, Bet A, Mennes M, van Oort E, Beckmann CF, Braithwaite SP, Jackson S, Nikolich K, Stephens D, Kerchner GA, Wyss-Coray T.

JAMA Neurol. 2019 Jan 1;76(1):35-40. doi: 10.1001/jamaneurol.2018.3288.

7.

Individual differences in associative memory among older adults explained by hippocampal subfield structure and function.

Carr VA, Bernstein JD, Favila SE, Rutt BK, Kerchner GA, Wagner AD.

Proc Natl Acad Sci U S A. 2017 Nov 7;114(45):12075-12080. doi: 10.1073/pnas.1713308114. Epub 2017 Oct 23.

8.

A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci.

Chang D, Nalls MA, Hallgrímsdóttir IB, Hunkapiller J, van der Brug M, Cai F; International Parkinson's Disease Genomics Consortium; 23andMe Research Team, Kerchner GA, Ayalon G, Bingol B, Sheng M, Hinds D, Behrens TW, Singleton AB, Bhangale TR, Graham RR.

Nat Genet. 2017 Oct;49(10):1511-1516. doi: 10.1038/ng.3955. Epub 2017 Sep 11.

9.

A harmonized segmentation protocol for hippocampal and parahippocampal subregions: Why do we need one and what are the key goals?

Wisse LEM, Daugherty AM, Olsen RK, Berron D, Carr VA, Stark CEL, Amaral RSC, Amunts K, Augustinack JC, Bender AR, Bernstein JD, Boccardi M, Bocchetta M, Burggren A, Chakravarty MM, Chupin M, Ekstrom A, de Flores R, Insausti R, Kanel P, Kedo O, Kennedy KM, Kerchner GA, LaRocque KF, Liu X, Maass A, Malykhin N, Mueller SG, Ofen N, Palombo DJ, Parekh MB, Pluta JB, Pruessner JC, Raz N, Rodrigue KM, Schoemaker D, Shafer AT, Steve TA, Suthana N, Wang L, Winterburn JL, Yassa MA, Yushkevich PA, la Joie R; Hippocampal Subfields Group.

Hippocampus. 2017 Jan;27(1):3-11. doi: 10.1002/hipo.22671. Epub 2016 Nov 15.

10.

Cross-species translation of the Morris maze for Alzheimer's disease.

Possin KL, Sanchez PE, Anderson-Bergman C, Fernandez R, Kerchner GA, Johnson ET, Davis A, Lo I, Bott NT, Kiely T, Fenesy MC, Miller BL, Kramer JH, Finkbeiner S.

J Clin Invest. 2016 Feb;126(2):779-83. doi: 10.1172/JCI78464. Epub 2016 Jan 19.

11.

Quantitative comparison of 21 protocols for labeling hippocampal subfields and parahippocampal subregions in in vivo MRI: towards a harmonized segmentation protocol.

Yushkevich PA, Amaral RS, Augustinack JC, Bender AR, Bernstein JD, Boccardi M, Bocchetta M, Burggren AC, Carr VA, Chakravarty MM, Chételat G, Daugherty AM, Davachi L, Ding SL, Ekstrom A, Geerlings MI, Hassan A, Huang Y, Iglesias JE, La Joie R, Kerchner GA, LaRocque KF, Libby LA, Malykhin N, Mueller SG, Olsen RK, Palombo DJ, Parekh MB, Pluta JB, Preston AR, Pruessner JC, Ranganath C, Raz N, Schlichting ML, Schoemaker D, Singh S, Stark CE, Suthana N, Tompary A, Turowski MM, Van Leemput K, Wagner AD, Wang L, Winterburn JL, Wisse LE, Yassa MA, Zeineh MM; Hippocampal Subfields Group (HSG).

Neuroimage. 2015 May 1;111:526-41. doi: 10.1016/j.neuroimage.2015.01.004. Epub 2015 Jan 14.

12.

Noninvasive in vivo monitoring of tissue-specific global gene expression in humans.

Koh W, Pan W, Gawad C, Fan HC, Kerchner GA, Wyss-Coray T, Blumenfeld YJ, El-Sayed YY, Quake SR.

Proc Natl Acad Sci U S A. 2014 May 20;111(20):7361-6. doi: 10.1073/pnas.1405528111. Epub 2014 May 5. Erratum in: Proc Natl Acad Sci U S A. 2014 Jul 29;111(30):11223.

13.

Optimization of magnetization-prepared 3-dimensional fluid attenuated inversion recovery imaging for lesion detection at 7 T.

Saranathan M, Tourdias T, Kerr AB, Bernstein JD, Kerchner GA, Han MH, Rutt BK.

Invest Radiol. 2014 May;49(5):290-8. doi: 10.1097/RLI.0000000000000041.

14.

APOE ε4 worsens hippocampal CA1 apical neuropil atrophy and episodic memory.

Kerchner GA, Berdnik D, Shen JC, Bernstein JD, Fenesy MC, Deutsch GK, Wyss-Coray T, Rutt BK.

Neurology. 2014 Feb 25;82(8):691-7. doi: 10.1212/WNL.0000000000000154. Epub 2014 Jan 22.

15.

Shared vulnerability of two synaptically-connected medial temporal lobe areas to age and cognitive decline: a seven tesla magnetic resonance imaging study.

Kerchner GA, Bernstein JD, Fenesy MC, Deutsch GK, Saranathan M, Zeineh MM, Rutt BK.

J Neurosci. 2013 Oct 16;33(42):16666-72. doi: 10.1523/JNEUROSCI.1915-13.2013.

16.

Influenza-associated global amnesia and hippocampal imaging abnormality.

Lopez J, Lomen-Hoerth C, Deutsch GK, Kerchner GA, Koshy A.

Neurocase. 2014 Aug;20(4):446-51. doi: 10.1080/13554794.2013.791864. Epub 2013 May 22.

17.

Cognitive processing speed in older adults: relationship with white matter integrity.

Kerchner GA, Racine CA, Hale S, Wilheim R, Laluz V, Miller BL, Kramer JH.

PLoS One. 2012;7(11):e50425. doi: 10.1371/journal.pone.0050425. Epub 2012 Nov 21.

18.

Novel presenilin-1 Y159F sequence variant associated with early-onset Alzheimer's disease.

Kerchner GA, Holbrook K.

Neurosci Lett. 2012 Dec 7;531(2):142-4. doi: 10.1016/j.neulet.2012.10.037. Epub 2012 Nov 2.

PMID:
23123781
19.

From Alois to Amyvid: seeing Alzheimer disease.

Furst AJ, Kerchner GA.

Neurology. 2012 Oct 16;79(16):1628-9. doi: 10.1212/WNL.0b013e3182662084. Epub 2012 Jul 11. No abstract available.

PMID:
22786589
20.

Hippocampal CA1 apical neuropil atrophy and memory performance in Alzheimer's disease.

Kerchner GA, Deutsch GK, Zeineh M, Dougherty RF, Saranathan M, Rutt BK.

Neuroimage. 2012 Oct 15;63(1):194-202. doi: 10.1016/j.neuroimage.2012.06.048. Epub 2012 Jul 3.

21.

A 44-year-old man with profound behavioural changes.

Laforce R Jr, Kerchner GA, Rabinovici GD, Fong JC, Miller BL, Seeley WW, Grinberg LT.

Can J Neurol Sci. 2012 Jul;39(4):527-30. No abstract available.

22.

Amyloid imaging for Alzheimer's disease.

Kerchner GA.

Expert Opin Med Diagn. 2011 Nov;5(6):527-38. doi: 10.1517/17530059.2011.617365. Epub 2011 Oct 18.

PMID:
23484750
23.

Ultra-high field 7T MRI: a new tool for studying Alzheimer's disease.

Kerchner GA.

J Alzheimers Dis. 2011;26 Suppl 3:91-5. doi: 10.3233/JAD-2011-0023.

PMID:
21971453
24.

Abhorring the vacuum: use of Alzheimer’s disease medications in frontotemporal dementia.

Kerchner GA, Tartaglia MC, Boxer A.

Expert Rev Neurother. 2011 May;11(5):709-17. doi: 10.1586/ern.11.6. Review.

25.

Hippocampal CA1 apical neuropil atrophy in mild Alzheimer disease visualized with 7-T MRI.

Kerchner GA, Hess CP, Hammond-Rosenbluth KE, Xu D, Rabinovici GD, Kelley DA, Vigneron DB, Nelson SJ, Miller BL.

Neurology. 2010 Oct 12;75(15):1381-7. doi: 10.1212/WNL.0b013e3181f736a1.

26.

Bapineuzumab.

Kerchner GA, Boxer AL.

Expert Opin Biol Ther. 2010 Jul;10(7):1121-30. doi: 10.1517/14712598.2010.493872. Review.

27.

Silent synapses and the emergence of a postsynaptic mechanism for LTP.

Kerchner GA, Nicoll RA.

Nat Rev Neurosci. 2008 Nov;9(11):813-25. doi: 10.1038/nrn2501. Epub 2008 Oct 15. Review. Erratum in: Nat Rev Neurosci. 2009 Mar;10(3):242.

28.

Critical role for TARPs in early development despite broad functional redundancy.

Menuz K, Kerchner GA, O'Brien JL, Nicoll RA.

Neuropharmacology. 2009 Jan;56(1):22-9. doi: 10.1016/j.neuropharm.2008.06.037. Epub 2008 Jun 27.

29.

Co-occurrence of a cavernous malformation and contralateral moyamoya.

Kerchner GA, Smith W, Lawton MT, Singh V.

Neurology. 2006 May 23;66(10):1601-2. No abstract available.

PMID:
16717235
30.

Kainate receptor subunits underlying presynaptic regulation of transmitter release in the dorsal horn.

Kerchner GA, Wilding TJ, Huettner JE, Zhuo M.

J Neurosci. 2002 Sep 15;22(18):8010-7.

31.
32.

Glutamate and the presynaptic control of spinal sensory transmission.

Huettner JE, Kerchner GA, Zhuo M.

Neuroscientist. 2002 Apr;8(2):89-92. Review.

PMID:
11954562
33.

Direct presynaptic regulation of GABA/glycine release by kainate receptors in the dorsal horn: an ionotropic mechanism.

Kerchner GA, Wang GD, Qiu CS, Huettner JE, Zhuo M.

Neuron. 2001 Nov 8;32(3):477-88.

34.

Genetic enhancement of inflammatory pain by forebrain NR2B overexpression.

Wei F, Wang GD, Kerchner GA, Kim SJ, Xu HM, Chen ZF, Zhuo M.

Nat Neurosci. 2001 Feb;4(2):164-9.

PMID:
11175877
35.

Presynaptic kainate receptors regulate spinal sensory transmission.

Kerchner GA, Wilding TJ, Li P, Zhuo M, Huettner JE.

J Neurosci. 2001 Jan 1;21(1):59-66.

36.

Zn2+ current is mediated by voltage-gated Ca2+ channels and enhanced by extracellular acidity in mouse cortical neurones.

Kerchner GA, Canzoniero LM, Yu SP, Ling C, Choi DW.

J Physiol. 2000 Oct 1;528 Pt 1:39-52.

37.

Zinc-induced neuronal death in cortical neurons.

Lobner D, Canzoniero LM, Manzerra P, Gottron F, Ying H, Knudson M, Tian M, Dugan LL, Kerchner GA, Sheline CT, Korsmeyer SJ, Choi DW.

Cell Mol Biol (Noisy-le-grand). 2000 Jun;46(4):797-806.

PMID:
10875441
38.

Speaking out of turn: a role for silent synapses in pain.

Kerchner GA, Li P, Zhuo M.

IUBMB Life. 1999 Sep;48(3):251-6. Review.

39.

AMPA receptor-PDZ interactions in facilitation of spinal sensory synapses.

Li P, Kerchner GA, Sala C, Wei F, Huettner JE, Sheng M, Zhuo M.

Nat Neurosci. 1999 Nov;2(11):972-7.

PMID:
10526335
40.

Genetic enhancement of learning and memory in mice.

Tang YP, Shimizu E, Dube GR, Rampon C, Kerchner GA, Zhuo M, Liu G, Tsien JZ.

Nature. 1999 Sep 2;401(6748):63-9.

PMID:
10485705
41.

Endogenous voltage-gated potassium channels in human embryonic kidney (HEK293) cells.

Yu SP, Kerchner GA.

J Neurosci Res. 1998 Jun 1;52(5):612-7.

PMID:
9632317
42.

Measurement of intracellular free zinc in living cortical neurons: routes of entry.

Sensi SL, Canzoniero LM, Yu SP, Ying HS, Koh JY, Kerchner GA, Choi DW.

J Neurosci. 1997 Dec 15;17(24):9554-64.

43.

Autoradiographic localization of insulin-like growth factor II receptors in cerebellar cortex of weaver and Purkinje cell degeneration mutant mice.

Mendelsohn LG, Smith MC, Lucaites VL, Kerchner GA, Ghetti B.

Brain Res. 1988 Aug 23;458(2):361-6.

PMID:
2850081
44.

The insulin-like growth factor-II (IGF-II) receptor of rat brain: regional distribution visualized by autoradiography.

Smith M, Clemens J, Kerchner GA, Mendelsohn LG.

Brain Res. 1988 Apr 5;445(2):241-6.

PMID:
2967099
45.

Sigma opioid receptor: characterization and co-identity with the phencyclidine receptor.

Mendelsohn LG, Kalra V, Johnson BG, Kerchner GA.

J Pharmacol Exp Ther. 1985 Jun;233(3):597-602.

PMID:
2989489
46.

Nasal delivery of polypeptides I: nasal absorption of enkephalins in rats.

Su KS, Campanale KM, Mendelsohn LG, Kerchner GA, Gries CL.

J Pharm Sci. 1985 Apr;74(4):394-8.

PMID:
3889275
47.

Immunoregulation by opioid peptides: I. Absence of classical opioid receptor on human mononuclear cells.

Mendelsohn LG, Kerchner GA, Culwell M, Ades EW.

J Clin Lab Immunol. 1985 Mar;16(3):125-9.

PMID:
2993625
48.

Phencyclidine receptors in rat brain cortex.

Mendelsohn LG, Kerchner GA, Kalra V, Zimmerman DM, Leander JD.

Biochem Pharmacol. 1984 Nov 15;33(22):3529-35.

PMID:
6095851
49.

Studies on the transport of enkephalin-like oligopeptides in rat intestinal mucosa.

Kerchner GA, Geary LE.

J Pharmacol Exp Ther. 1983 Jul;226(1):33-8.

PMID:
6345754
50.

Subacute toxicity of ethylenebisisothiocyanate sulfide in the laboratory rat.

Freudenthal RI, Kerchner GA, Persing RL, Baumel I, Baron RL.

J Toxicol Environ Health. 1977 May;2(5):1067-78. No abstract available.

PMID:
864780

Supplemental Content

Loading ...
Support Center